NO145792C - Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater

Info

Publication number
NO145792C
NO145792C NO763371A NO763371A NO145792C NO 145792 C NO145792 C NO 145792C NO 763371 A NO763371 A NO 763371A NO 763371 A NO763371 A NO 763371A NO 145792 C NO145792 C NO 145792C
Authority
NO
Norway
Prior art keywords
pyrimidon
derivatives
preparation
pharmacologically active
analogy procedure
Prior art date
Application number
NO763371A
Other languages
English (en)
Norwegian (no)
Other versions
NO763371L (ja
NO145792B (no
Inventor
Thomas Henry Brown
John Colin Emmett
Graham John Durant
Charon Robin Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO763371L publication Critical patent/NO763371L/no
Publication of NO145792B publication Critical patent/NO145792B/no
Publication of NO145792C publication Critical patent/NO145792C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO763371A 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater NO145792C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (3)

Publication Number Publication Date
NO763371L NO763371L (ja) 1977-04-05
NO145792B NO145792B (no) 1982-02-22
NO145792C true NO145792C (no) 1982-06-02

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763371A NO145792C (no) 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater

Country Status (36)

Country Link
JP (2) JPS5246087A (ja)
AR (1) AR221682A1 (ja)
AT (1) AT358045B (ja)
AU (1) AU504897B2 (ja)
BE (1) BE846452A (ja)
BG (1) BG25224A3 (ja)
CA (1) CA1067076A (ja)
CH (1) CH625801A5 (ja)
CS (1) CS203003B2 (ja)
DD (1) DD126563A5 (ja)
DE (1) DE2643670C2 (ja)
DK (1) DK442476A (ja)
ES (1) ES452060A1 (ja)
FI (1) FI61701C (ja)
FR (1) FR2326192A1 (ja)
GR (1) GR61307B (ja)
HU (1) HU175537B (ja)
IE (1) IE44845B1 (ja)
IL (1) IL50503A (ja)
IN (1) IN146736B (ja)
IT (2) IT1070839B (ja)
LU (1) LU75922A1 (ja)
MW (1) MW3476A1 (ja)
MX (1) MX4614E (ja)
NL (1) NL7609917A (ja)
NO (1) NO145792C (ja)
NZ (1) NZ181959A (ja)
OA (1) OA05445A (ja)
PH (1) PH13921A (ja)
PL (1) PL105828B1 (ja)
PT (1) PT65590B (ja)
RO (1) RO73511A (ja)
SE (1) SE431872B (ja)
YU (1) YU237276A (ja)
ZA (1) ZA765498B (ja)
ZM (1) ZM12176A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (ja) * 1978-02-13 1983-03-05 Smith Kline French Lab
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
FR2326192B1 (ja) 1979-01-12
CS203003B2 (en) 1981-02-27
CH625801A5 (en) 1981-10-15
ZA765498B (en) 1977-08-31
RO73511A (ro) 1981-04-30
BG25224A3 (en) 1978-08-10
IE44845B1 (en) 1982-04-21
FR2326192A1 (fr) 1977-04-29
HU175537B (hu) 1980-08-28
JPS609755B2 (ja) 1985-03-12
PL105828B1 (pl) 1979-11-30
GR61307B (en) 1978-10-19
ES452060A1 (es) 1977-10-01
PT65590A (en) 1976-10-01
AU1829576A (en) 1978-04-06
DE2643670A1 (de) 1977-04-14
IE44845L (en) 1977-04-02
ATA711976A (de) 1980-01-15
LU75922A1 (ja) 1977-05-06
CA1067076A (en) 1979-11-27
YU237276A (en) 1983-01-21
IL50503A0 (en) 1976-11-30
JPS5246087A (en) 1977-04-12
FI61701C (fi) 1982-09-10
DE2643670C2 (de) 1982-07-01
DD126563A5 (ja) 1977-07-27
NO763371L (ja) 1977-04-05
PH13921A (en) 1980-11-04
MW3476A1 (en) 1977-11-09
BE846452A (fr) 1977-03-22
MX4614E (es) 1982-07-07
AR221682A1 (es) 1981-03-13
SE7610409L (sv) 1977-04-03
JPS5695186A (en) 1981-08-01
JPS5635674B2 (ja) 1981-08-19
AT358045B (de) 1980-08-11
NL7609917A (nl) 1977-04-05
ZM12176A1 (en) 1977-07-21
FI762803A (ja) 1977-04-03
DK442476A (da) 1977-04-03
IL50503A (en) 1980-12-31
NO145792B (no) 1982-02-22
SE431872B (sv) 1984-03-05
FI61701B (fi) 1982-05-31
AU504897B2 (en) 1979-11-01
PT65590B (en) 1978-03-28
IN146736B (ja) 1979-08-25
IT1070839B (it) 1985-04-02
NZ181959A (en) 1978-07-28
IT7830708A0 (it) 1978-12-11
OA05445A (fr) 1981-03-31

Similar Documents

Publication Publication Date Title
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO143744C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benz(de)isokinolin-derivater
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler